Document is current
Any future updates will be listed below
-
Authors
Yu, Nuo
Chen, Xiankai
Li, Jiao
Kang, Xiaozheng
Wang, Zhen
Zhang, Ruixiang
Qin, Jianjun
Li, Yong
Zheng, Qingfeng
Feng, Guojie
Deng, Lei
Zhang, Tao
Wang, Wenqing
Liu, Wenyang
Wang, Jianyang
Feng, Qinfu
Lv, Jima
Zhou, Zongmei
Xiao, Zefen
Bi, Nan
Li, Yin
Wang, Xin
-
Funding
Funding for this research was provided by:
Beijing Xisike Clinical Oncology Research Foundation (Y-Young2023-0114)
- License Information
-
More Information
Article History
Received: 16 May 2024
Accepted: 24 July 2024
First Online: 12 August 2024
Declarations
:
: N. Yu, X. Chen, J. Li, X. Kang, Z. Wang, R. Zhang, J. Qin, Y. Li, Q. Zheng, G. Feng, L. Deng, T. Zhang, W. Wang, W. Liu, J. Wang, Q. Feng, J. Lv, Z. Zhou, Z. Xiao, N. Bi, Y. Li and X. Wang declare that they have no competing interests.
: Information of this clinical trial: This trial has been aprroved by the Ethics Committee of National Cancer Center. The file number is 19/325-2109 and the registration number at clinicaltrials.gov is NCT04278287. All studies mentioned were in accordance with the ethical standards indicated in each case.
